Vir Biotechnology (VIR) Gross Profit (2020 - 2026)

Vir Biotechnology has reported Gross Profit for 6 years, with the latest figure at $1.2 million in Q2 2025.

• Quarterly Gross Profit fell 60.21% year-over-year to $1.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $18.3 million (down 75.08% YoY) and the FY2025 annual result came in at $68.5 million, down 6.58% from the prior year.
• Gross Profit eased to $1.2 million in Q2 2025 per VIR's latest filing, from $3.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $1.1 billion in Q1 2022 and troughed at $1.2 million in Q2 2025.
• A 5-year average of $151.5 million and a median of $14.3 million in 2022 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2023: Gross Profit jumped 57709.21% in 2022, then sank 99.26% in 2023.
• Over 5 years, Gross Profit stood at $755.9 million in 2021, then sank by 94.26% to $43.4 million in 2022, then plunged by 63.17% to $16.0 million in 2023, then dropped by 26.89% to $11.7 million in 2024, then sank by 89.71% to $1.2 million in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $1.2 million, $3.0 million, and $11.7 million for Q2 2025, Q1 2025, and Q4 2024 respectively.